thyroxine has been researched along with Adrenal Hyperplasia, Congenital in 6 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Adrenal Hyperplasia, Congenital: A group of inherited disorders of the ADRENAL GLANDS, caused by enzyme defects in the synthesis of cortisol (HYDROCORTISONE) and/or ALDOSTERONE leading to accumulation of precursors for ANDROGENS. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in STEROID 21-HYDROXYLASE; STEROID 11-BETA-HYDROXYLASE; STEROID 17-ALPHA-HYDROXYLASE; 3-beta-hydroxysteroid dehydrogenase (3-HYDROXYSTEROID DEHYDROGENASES); TESTOSTERONE 5-ALPHA-REDUCTASE; or steroidogenic acute regulatory protein; among others, underlie these disorders.
Excerpt | Relevance | Reference |
---|---|---|
"The purpose of this study was to determine whether polycystic ovary syndrome (PCOS) and nonclassic 21-hydroxylase deficiency (CAH) are related to hyperhomocysteinemia, and to investigate if there is a correlation between homocysteine levels and insulin sensitivity in women with PCOS and CAH." | 7.72 | Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia. ( Bayraktar, F; Dereli, D; Ozgen, AG; Yilmaz, C, 2004) |
"The purpose of this study was to determine whether polycystic ovary syndrome (PCOS) and nonclassic 21-hydroxylase deficiency (CAH) are related to hyperhomocysteinemia, and to investigate if there is a correlation between homocysteine levels and insulin sensitivity in women with PCOS and CAH." | 3.72 | Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia. ( Bayraktar, F; Dereli, D; Ozgen, AG; Yilmaz, C, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mitchell, ML | 1 |
Hsu, HW | 1 |
Sahai, I | 1 |
Bayraktar, F | 1 |
Dereli, D | 1 |
Ozgen, AG | 1 |
Yilmaz, C | 1 |
Miyai, K | 1 |
Mizuta, H | 1 |
Benjamin, F | 1 |
Deutsch, S | 1 |
Saperstein, H | 1 |
Seltzer, VL | 1 |
Rieger, H | 1 |
4 reviews available for thyroxine and Adrenal Hyperplasia, Congenital
Article | Year |
---|---|
Changing perspectives in screening for congenital hypothyroidism and congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Clinical Laboratory Techniques; Conge | 2014 |
[Recent progress in radioisotope in vitro test (author's transl)].
Topics: Adrenal Hyperplasia, Congenital; alpha-Fetoproteins; Animals; Antibody Specificity; Carcinoembryonic | 1981 |
[III. Clinical diagnosis by immunoassay: mass screening].
Topics: Adrenal Hyperplasia, Congenital; Congenital Hypothyroidism; Female; Humans; Immunoenzyme Techniques; | 1983 |
[Pathogenesis of various forms of arterial hypertension].
Topics: Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Aging; Aortic Coarctation; Aortic Valve In | 1971 |
2 other studies available for thyroxine and Adrenal Hyperplasia, Congenital
Article | Year |
---|---|
Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia.
Topics: Adrenal Hyperplasia, Congenital; Adult; Blood Glucose; Cholesterol; Estradiol; Female; Follicle Stim | 2004 |
Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Dehydroe | 1986 |